These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38806260)

  • 1. Breast Cancer Screening During the COVID-19 Pandemic in the United States: Results From Real-World Health Records Data.
    Chung A; Chen Q; Curry W; Felix T; Tuan WJ
    Ann Fam Med; 2024; 22(3):208-214. PubMed ID: 38806260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of Breast Cancer Screening Adherence During the COVID-19 Pandemic in a Cohort at Increased Inherited Cancer Risk in the United States.
    Harris A; Bather JR; Kawamoto K; Fiol GD; Bradshaw RL; Kaiser-Jackson L; Monahan R; Kohlmann W; Liu F; Ginsburg O; Goodman MS; Kaphingst KA
    Cancer Control; 2024; 31():10732748241272727. PubMed ID: 39420801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Health Care Access and Preventive Health Screenings by Race and Ethnicity.
    Alba C; Zheng Z; Wadhera RK
    JAMA Health Forum; 2024 Feb; 5(2):e235058. PubMed ID: 38306093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. State Variation in Racial and Ethnic Disparities in Incidence of Triple-Negative Breast Cancer Among US Women.
    Sung H; Wiese D; Jatoi I; Jemal A
    JAMA Oncol; 2023 May; 9(5):700-704. PubMed ID: 36862439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Considerations to increase rates of breast cancer screening across populations.
    Patt D; Gordan L; Patel K; Okon T; Ferreyros N; Markward N; Sullivan M; Burnett B; Getachew B; Harris C
    Am J Manag Care; 2022 Apr; 28(3 Spec. No.):SP136-SP138. PubMed ID: 35285592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in Screening Test Volume in the National Breast and Cervical Cancer Early Detection Program during the COVID-19 Pandemic, 2020-2022.
    Bermudez Y; DeGroff A; Miller J; Kenney K; Lockhart J; Joseph D; Richardson L
    Int J Environ Res Public Health; 2024 Jun; 21(7):. PubMed ID: 39063394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Race and Ethnicity-Adjusted Age Recommendation for Initiating Breast Cancer Screening.
    Chen T; Kharazmi E; Fallah M
    JAMA Netw Open; 2023 Apr; 6(4):e238893. PubMed ID: 37074714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Care Quality and Equity in Health Centers During and After the COVID-19 Pandemic.
    McGrath BM; Goueth R; Jones MWH; Cook N; Navale SM; Zyzanski SJ; Bensken WP; Templeton AR; Koroukian SM; Crist RL; Stange KC
    Am J Prev Med; 2024 Oct; 67(4):485-493. PubMed ID: 38788862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years + .
    Monsivais P; Amiri S; Robison J; Pflugeisen C; Kordas G; Amram O
    Breast Cancer; 2022 Jul; 29(4):740-746. PubMed ID: 35366175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States.
    DeGroff A; Miller J; Sharma K; Sun J; Helsel W; Kammerer W; Rockwell T; Sheu A; Melillo S; Uhd J; Kenney K; Wong F; Saraiya M; Richardson LC
    Prev Med; 2021 Oct; 151():106559. PubMed ID: 34217410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Mammography Use by Women's Characteristics During the First 5 Months of the COVID-19 Pandemic.
    Sprague BL; Lowry KP; Miglioretti DL; Alsheik N; Bowles EJA; Tosteson ANA; Rauscher G; Herschorn SD; Lee JM; Trentham-Dietz A; Weaver DL; Stout NK; Kerlikowske K
    J Natl Cancer Inst; 2021 Sep; 113(9):1161-1167. PubMed ID: 33778894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung Cancer Screening by Race and Ethnicity in an Integrated Health System in Hawaii.
    Oshiro CES; Frankland TB; Mor J; Wong CP; Martinez YT; Aruga CKK; Honda S
    JAMA Netw Open; 2022 Jan; 5(1):e2144381. PubMed ID: 35050353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast and cervical cancer screenings across gender identity: results from the Behavioral Risk Factor Surveillance System before and during the COVID-19 pandemic.
    Berzansky I; Reynolds CA; Charlton BM
    Cancer Causes Control; 2024 May; 35(5):865-872. PubMed ID: 38280155
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in Breast Cancer Subtype Incidence and Distribution by Race/Ethnicity in the United States From 2010 to 2015.
    Kong X; Liu Z; Cheng R; Sun L; Huang S; Fang Y; Wang J
    JAMA Netw Open; 2020 Oct; 3(10):e2020303. PubMed ID: 33074325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population-level impact of coronavirus disease 2019 on breast cancer screening and diagnostic procedures.
    Nyante SJ; Benefield TS; Kuzmiak CM; Earnhardt K; Pritchard M; Henderson LM
    Cancer; 2021 Jun; 127(12):2111-2121. PubMed ID: 33635541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in breast cancer screening during the COVID-19 pandemic within a universally insured health system in the United States, 2017-2022.
    Mani V; Banaag A; Munigala S; Umoh A; Schoenfeld AJ; Coles CL; Koehlmoos TP
    Cancer Med; 2023 Sep; 12(18):19126-19136. PubMed ID: 37641528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceived discrimination is associated with reduced breast and cervical cancer screening: the Study of Women's Health Across the Nation (SWAN).
    Jacobs EA; Rathouz PJ; Karavolos K; Everson-Rose SA; Janssen I; Kravitz HM; Lewis TT; Powell LH
    J Womens Health (Larchmt); 2014 Feb; 23(2):138-45. PubMed ID: 24261647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The negative impact of the COVID-19 pandemic on breast cancer care in Brazil: a time series study in regions with different human development indices.
    Hyeda A; da Costa ÉSM; Kowalski SC
    BMC Public Health; 2024 Nov; 24(1):3047. PubMed ID: 39501237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in breast and prostate cancer screening and diagnostic procedures during the COVID-19 pandemic in central Massachusetts.
    Epstein MM; Sundaresan D; Fair M; Fouayzi H; Warner ET; Garber LD; Gurwitz JH; Field TS
    Cancer Causes Control; 2022 Oct; 33(10):1313-1323. PubMed ID: 35933572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.